EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Peroxisome Proliferator-activated Receptor Gamma Serum Levels and Gene Polymorphism in Frontal Fibrosing Alopecia: A Case–Control Study

Assem Mohamed Farag, Dina El Adawy, Amira Mohamed Noureldin Abdelrahman, Shady Mahmoud Attia Ibrahim, Rehab Mohammed Salem

International Journal of Trichology · 2025-03 · 17 (2) · 106-112

DOI: 10.4103/ijt.ijt_11_23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Trichology, online erschienen am 04.11.2025. Verfasst von Assem Mohamed Farag und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Faculty of Medicine, Benha University, Banha, Egypt. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Frontal fibrosing alopecia (FFA) is a scarring alopecia with a complex pathogenesis that is not completely clear yet.

Objective

The aims of the study were to evaluate serum peroxisome proliferator-activated receptor gamma (PPARγ) levels and gene polymorphism in a sample of Egyptian FFA patients. Subjects and Methods: The case–control study included 93 FFA female patients and 157 matching apparently healthy control subjects. Patients were subjected to clinical and trichoscopic examinations to diagnose FFA according to the updated diagnostic criteria. FFA severity was evaluated using the FFA Severity Index (FFASI). Serum PPARγ levels and gene polymorphisms were assessed in all participants using enzyme-linked immunosorbent assay and polymerase chain reaction techniques, respectively.

Results

Serum PPARγ levels in the patients’ group were significantly lower than that of the control subjects’ group. PPARG (Pro12Ala) gene polymorphism was significantly predominant in FFA patients when compared to the control subjects. Patients carrying polymorphic genotypes showed significantly reduced serum PPARγ levels when compared to patients carrying the wild genotype. They also showed significantly higher FFASI in comparison to wild genotype carriers.

Conclusion

PPARγ may play an important role in FFA development. It might have a potential utility as a biomarker in FFA.

Schlagwörter

Stichwörter der Autor:innen

Frontal fibrosing alopeciagene polymorphismperoxisome proliferator-activated receptor gamma

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, Faculty of Medicine, Benha University, Banha, Egypt.
  • Department of Dermatology and Venereology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.

Zitieren

APA

Farag, A. M., El Adawy, D., Abdelrahman, A. M. N., Ibrahim, S. M. A., & Salem, R. M. (2025). Peroxisome Proliferator-activated Receptor Gamma Serum Levels and Gene Polymorphism in Frontal Fibrosing Alopecia: A Case–Control Study. International Journal of Trichology, 17(2), 106-112. https://doi.org/10.4103/ijt.ijt_11_23

Vancouver

Farag AM, El Adawy D, Abdelrahman AMN, Ibrahim SMA, Salem RM. Peroxisome Proliferator-activated Receptor Gamma Serum Levels and Gene Polymorphism in Frontal Fibrosing Alopecia: A Case–Control Study. International Journal of Trichology. 2025;17(2):106-112. doi:10.4103/ijt.ijt_11_23

BibTeX
@article{Farag2025,
  author = {Farag, Assem Mohamed and El Adawy, Dina and Abdelrahman, Amira Mohamed Noureldin and Ibrahim, Shady Mahmoud Attia and Salem, Rehab Mohammed},
  title = {Peroxisome Proliferator-activated Receptor Gamma Serum Levels and Gene Polymorphism in Frontal Fibrosing Alopecia: A Case–Control Study},
  journal = {International Journal of Trichology},
  year = {2025},
  volume = {17},
  number = {2},
  pages = {106--112},
  doi = {10.4103/ijt.ijt_11_23}
}
Kostenlos starten →